4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Roles of oral microbiota and oral-gut microbial transmission in hypertension

      research-article
      a , b , 1 , a , b , c , 1 , a , b , 1 , d , a , b , a , b , a , b , c , a , b , a , b , b , e , a , b , a , b , a , b , a , b , a , b , b , f , g , g , h , i , b , j , b , c , * , i , * , a , b , *
      Journal of Advanced Research
      Elsevier
      Oral microbiota, Gut microbiota, Oral-gut axis, Blood pressure, Hypertension, Veillonella, HTN, hypertension, PD, periodontitis, BP, blood pressure, SBP, systolic blood pressure, DBP, diastolic blood pressure, PCoA, Principal coordinate analysis, LEfSe, Linear discriminant analysis effect size, IL-6, Interleukin-6, SNV, single nucleotide variant, ABX, antibiotics cocktail, ANG II, angiotensin II, CRP, C-reactive protein

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Graphical abstract

          Highlights

          • This study has provided comprehensive evidence to support strong associations between oral microbiota and HTN. We discovered that 14 salivary genera and 15 subgingival genera were significantly altered in hypertension participants.

          • Fifteen oral genera were first found to associate with blood pressure. There were also new associations between oral microbiota and other clinical parameters been established.

          • This study has identified the shared genera that coexisted in saliva, subgingival plaques, and feces and illustrated the associations of the shared genera between oral and gut sample types.

          • This study has identified important oral-gut transmitting microbes in hypertension. Sixteen species under 5 genera were identified as oral-gut transmitters. Particularly, Veillonella was identified as a frequent oral-gut transmitter stably enriched in hypertension participants.

          • This study has demonstrated the potential causal link between oral-gut microbial transmission and hypertension—saliva from participants with hypertension exacerbated angiotensin II-induced hypertension in animal study. Veillonella could colonize in the gut of all mice receiving human saliva and more enriched in mice receiving saliva from hypertension participants.

          Abstract

          Introduction

          Considerable evidence has linked periodontitis (PD) to hypertension (HTN), but the nature behind this connection is unclear. Dysbiosis of oral microbiota leading to PD is known to aggravate different systematic diseases, but the alteration of oral microbiota in HTN and their impacts on blood pressure (BP) remains to be discovered.

          Objectives

          To characterize the alterations of oral and gut microbiota and their roles in HTN.

          Methods

          We performed a cross-sectional (95 HTN participants and 39 controls) and a 6-month follow-up study (52 HTN participants and 26 controls) to analyze the roles of oral and gut microbiota in HTN. Saliva, subgingival plaques, and feces were collected for 16S rRNA gene sequencing or metagenomic analysis. C57BL/6J mice were pretreated with antibiotics to deplete gut microbiota, and then transplanted with human saliva by gavage to test the impacts of abnormal oral-gut microbial transmission on HTN.

          Results

          BP in participants with PD was higher than no PD in both cross-sectional and follow-up cohort. Relative abundances of 14 salivary genera, 15 subgingival genera and 10 gut genera significantly altered in HTN and those of 7 salivary genera, 12 subgingival genera and 6 gut genera significantly correlated with BP. Sixteen species under 5 genera were identified as oral-gut transmitters, illustrating the presence of oral-gut microbial transmission in HTN. Veillonella was a frequent oral-gut transmitter stably enriched in HTN participants of both cross-sectional and follow-up cohorts. Saliva from HTN participants increased BP in hypertensive mice. Human saliva-derived Veillonella successfully colonized in mouse gut, more abundantly under HTN condition.

          Conclusions

          PD and oral microbiota are strongly associated with HTN, likely through oral-gut transmission of microbes. Ectopic colonization of saliva-derived Veillonella in the gut may aggravate HTN. Therefore, precise manipulations of oral microbiota and/or oral-gut microbial transmission may be useful strategies for better prevention and treatment of HTN.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

          Gut microbiota are linked to chronic inflammation and carcinogenesis. Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer patients. Here, we investigated the contribution of gut microbiota to chemoresistance in patients with colorectal cancer. We found that Fusobacterium (F.) nucleatum was abundant in colorectal cancer tissues in patients with recurrence post chemotherapy, and was associated with patient clinicopathological characterisitcs. Furthermore, our bioinformatic and functional studies demonstrated that F. nucleatum promoted colorectal cancer resistance to chemotherapy. Mechanistically, F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter colorectal cancer chemotherapeutic response. Thus, F. nucleatum orchestrates a molecular network of the Toll-like receptor, microRNAs, and autophagy to clinically, biologically, and mechanistically control colorectal cancer chemoresistance. Measuring and targeting F. nucleatum and its associated pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer patient outcomes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

            Increasing evidence links the gut microbiota with colorectal cancer. Metagenomic analyses indicate that symbiotic Fusobacterium spp. are associated with human colorectal carcinoma, but whether this is an indirect or causal link remains unclear. We find that Fusobacterium spp. are enriched in human colonic adenomas relative to surrounding tissues and in stool samples from colorectal adenoma and carcinoma patients compared to healthy subjects. Additionally, in the Apc(Min/+) mouse model of intestinal tumorigenesis, Fusobacterium nucleatum increases tumor multiplicity and selectively recruits tumor-infiltrating myeloid cells, which can promote tumor progression. Tumors from Apc(Min/+) mice exposed to F. nucleatum exhibit a proinflammatory expression signature that is shared with human fusobacteria-positive colorectal carcinomas. However, unlike other bacteria linked to colorectal carcinoma, F. nucleatum does not exacerbate colitis, enteritis, or inflammation-associated intestinal carcinogenesis. Collectively, these data suggest that, through recruitment of tumor-infiltrating immune cells, fusobacteria generate a proinflammatory microenvironment that is conducive for colorectal neoplasia progression. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Periodontal diseases

              Periodontal diseases comprise a wide range of inflammatory conditions that affect the supporting structures of the teeth (the gingiva, bone and periodontal ligament), which could lead to tooth loss and contribute to systemic inflammation. Chronic periodontitis predominantly affects adults, but aggressive periodontitis may occasionally occur in children. Periodontal disease initiation and propagation is through a dysbiosis of the commensal oral microbiota (dental plaque), which then interacts with the immune defences of the host, leading to inflammation and disease. This pathophysiological situation persists through bouts of activity and quiescence, until the affected tooth is extracted or the microbial biofilm is therapeutically removed and the inflammation subsides. The severity of the periodontal disease depends on environmental and host risk factors, both modifiable (for example, smoking) and non-modifiable (for example, genetic susceptibility). Prevention is achieved with daily self-performed oral hygiene and professional removal of the microbial biofilm on a quarterly or bi-annual basis. New treatment modalities that are actively explored include antimicrobial therapy, host modulation therapy, laser therapy and tissue engineering for tissue repair and regeneration.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Adv Res
                J Adv Res
                Journal of Advanced Research
                Elsevier
                2090-1232
                2090-1224
                19 March 2022
                January 2023
                19 March 2022
                : 43
                : 147-161
                Affiliations
                [a ]Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [b ]National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai, China
                [c ]Department of General Dentistry, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [d ]Department of Stomatology, First Affiliated Hospital, Anhui Medical University, Hefei, China
                [e ]Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [f ]Department of Preventive Dentistry, Shanghai Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [g ]Department of Human Microbiome, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China
                [h ]Department of Clinical Immunology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [i ]Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                [j ]Department of Oral and Maxillofacial Implantology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                Author notes
                [* ]Corresponding authors at: Department of General Dentistry, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai 200011, China (Ya-Qin Zhu), Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, China 200011 (Huili Zhang) and Shanghai Ninth People's Hospital Research Center, Shanghai Jiao Tong University School of Medicine, 115 Jinzun Road, Shanghai, China 200125 (Sheng-Zhong Duan). zyq1590@ 123456163.com huilizhang815@ 123456163.com duansz@ 123456shsmu.edu.cn
                [1]

                These authors contributed equally to this article.

                Article
                S2090-1232(22)00069-8
                10.1016/j.jare.2022.03.007
                9811375
                36585105
                14d5c1f8-b124-4e79-b49f-6e403aca24d2
                © 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University.

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 7 January 2022
                : 7 March 2022
                : 8 March 2022
                Categories
                Original Article

                oral microbiota,gut microbiota,oral-gut axis,blood pressure,hypertension,veillonella,htn, hypertension,pd, periodontitis,bp, blood pressure,sbp, systolic blood pressure,dbp, diastolic blood pressure,pcoa, principal coordinate analysis,lefse, linear discriminant analysis effect size,il-6, interleukin-6,snv, single nucleotide variant,abx, antibiotics cocktail,ang ii, angiotensin ii,crp, c-reactive protein

                Comments

                Comment on this article